HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinogenicity of dinitropyrenes in the weanling female CD rat.

Abstract
The carcinogenicities of 1-nitropyrene and 1,3-, 1,6- and 1,8-dinitropyrene were assessed in weanling female CD rats. The animals were administered one of the compounds at 10 mumol/kg body wt through intraperitoneal or intragastric administration three times a week for 4 weeks. The total cumulative dose averaged 16 mumol/animal. The experiment was ended 78 weeks following the first administration. The average survival period for the animals in the 1,6- and 1,8-dinitropyrene i.p. treated groups, due to the occurrence of life-threatening peritoneal malignant fibrous histiocytomas (MFHs) in nearly all of the animals, were 19 and 38 weeks respectively. 1,3-Dinitropyrene induced only a few MFHs. 1,8-Dinitropyrene also induced a significant incidence of leukemia. A significant increase of the incidence of mammary tumors was observed in the groups of rats treated i.p. with 1-nitropyrene, or 1,3- or 1,8-dinitropyrene, and those treated i.g. with 1,8-dinitropyrene. These results demonstrate that nitropyrenes are capable of inducing MFH, mammary tumors and leukemia in the rat.
AuthorsK Imaida, M S Lee, C Y Wang, C M King
JournalCarcinogenesis (Carcinogenesis) Vol. 12 Issue 7 Pg. 1187-91 (Jul 1991) ISSN: 0143-3334 [Print] England
PMID1649014 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carcinogens
  • Pyrenes
  • 1,8-dinitropyrene
  • 1,6-dinitropyrene
  • 1,3-dinitropyrene
  • 1-nitropyrene
Topics
  • Adenocarcinoma (chemically induced)
  • Adenofibroma (chemically induced)
  • Animals
  • Carcinogens
  • Female
  • Histiocytoma, Benign Fibrous (chemically induced)
  • Leukemia, Experimental (chemically induced)
  • Mammary Neoplasms, Experimental (chemically induced)
  • Pyrenes (administration & dosage, toxicity)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: